Serratus Anterior Muscle

2020 ◽  
Author(s):  
2014 ◽  
Vol 30 (S 01) ◽  
Author(s):  
A. Gundeslioglu ◽  
Dem Özen ◽  
Lorenc Jasharllari ◽  
Nebil Selimolu ◽  
Figen Güney ◽  
...  

Author(s):  
Toshiyuki Watanabe ◽  
Hiroshi Matsumoto ◽  
Ryuichi Yoshida ◽  
Kazuya Yasui ◽  
Takahito Yagi ◽  
...  

1983 ◽  
Vol 63 (8) ◽  
pp. 1243-1247 ◽  
Author(s):  
Mary Alice Duncan ◽  
Michael T. Lotze ◽  
Lynn H. Gerber ◽  
Steven A. Rosenberg

1995 ◽  
Vol 88 ◽  
pp. S103
Author(s):  
Jamie A. Parker ◽  
William O. Thomas ◽  
Curtis N. Harris ◽  
Stephanie Moline ◽  
Larry L. Harper

2019 ◽  
Vol 12 (S 01) ◽  
pp. S50-S53
Author(s):  
Athanasios Karonidis ◽  
Akrivi Kostopoulou ◽  
Sofia Pappa ◽  
Dimosthenis Tsoutsos

AbstractThis article describes a rare case of giant cell tumor of the tendon sheath (GCTTS) that was developed over the substance of chimeric-free latissimus dorsi and ­serratus ­anterior muscle flaps performed for lower limb reconstruction. To our knowledge, development of GCTTS over a free flap is first described in the literature. A 71-year-old ­woman was presented with a large protuberant ulcerated tumor mass that was developed over the substance of chimeric free muscle flaps at the foot and ankle. We performed an extensive tumor resection, and the pathology report confirmed the presence of a primary giant cell tumor. The patient was advised to have a below-knee amputation. However, the patient refused the amputation, and 4 months later, she was presented with a metastatic mass proximally at the upper thigh. We believe that the GCTTS was associated with the chronic inflammation of the soft tissue and bones along with the recurrent episodes of infection, mainly due to proteus mirabilis and proteus syndrome (PS). PS may lead to the development of malformations and overgrowth of different tissues in unusual locations. In cases resistant to antibiotics, the radical surgical debridement should be considered as the most effective treatment.


2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Jun Hyeok Kim ◽  
Ye Sol Kim ◽  
Suk-Ho Moon ◽  
Young Joon Jun ◽  
Jong Won Rhie ◽  
...  

Background. In microvascular anastomosis, size discrepancy is common and can increase thrombotic complications. If size differences can be predicted, then vessels of the appropriate size can be selected. This study documented the difference in diameter between the thoracodorsal (TD) vessel and deep inferior epigastric perforator (DIEP) pedicle in each patient who underwent breast reconstruction using free tissue transfer. Patients and Methods. This retrospective study included 32 anastomoses (27 breasts including five cases of supercharged anastomosis) of breast reconstruction with the free DIEP flap and TD recipient between August 2018 and June 2019. In the microscopic view, the caliber of the TD vessel, the largest branch to the serratus anterior muscle, the descending branch, the largest and the second largest branches to the latissimus dorsi muscle, and the DIEP pedicle were measured. Results. The diameter of the deep inferior epigastric artery was similar to that of the descending branch, and their anastomosing rate was 56.3%. The diameter of the deep inferior epigastric vein was similar to the branch to the serratus anterior muscle and the descending branch, and their anastomosing rates were 29.3% and 29.3%, respectively. All flaps were survived; however, in one case, a reoperation was needed to remove the hematoma, in which case fat necrosis occurred as the only complication. Conclusion. TD branches of similar size to the DIEP pedicle were prioritized in anastomosis. The descending branch and the branch to the serratus anterior muscle are expected to be good candidates as recipients in breast reconstruction with DIEP free flap. Moreover, supercharged anastomosis of DIEP pedicles can be achieved within TD branches.


Sign in / Sign up

Export Citation Format

Share Document